NEW YORK, May 22, 2020 /PRNewswire/ -- The global
antiretroviral therapy market is anticipated to reach US$35.14 billion in 2024. The market is predicted
to experience growth at a CAGR of 3.40% during the period spanning
2020-2024. The growth in the antiretroviral therapy market is
supported by various factors including rising prevalence of HIV,
growing access to antiretroviral therapy, increasing intake of PrEP
and surging prevalence of mother-to-child transmission of HIV.
Read the full report:
https://www.reportlinker.com/p05897001/?utm_source=PRN
The market is also expected to face a trend of increasing use of
illicit drugs. The global antiretroviral therapy market is also
prone to certain challenges like increasing voluntary male
circumcisions and huge cost of treatment. The growing prevalence of
COVID-19 is also expected to boost the market as the healthcare
spending by government would rise. Moreover, patients suffering
from HIV are more prone to get infected by COVID-19 virus.
The global antiretroviral therapy market by drug type can be
segmented into the following: NRTI, NNRTI, protease inhibitors and
integrase inhibitors. The dominant share of the market in 2019 was
held by NRTI, followed by NNRTI, protease inhibitors and integrase
inhibitors.
The global antiretroviral therapy market by region can be segmented
into the following regions: North
America, Europe and
Asia Pacific. In 2019, the
dominant share of the market was held by North America, followed by Europe and Asia
Pacific. North America is
predicted to dominate the global antiretroviral therapy market,
supported by various factors like increasing funds on research
& development activity and surging number of coronavirus
infected cases.
Scope of the report:
The report provides a comprehensive analysis of the global
antiretroviral therapy market with potential impact of
COVID-19.
The major regional markets (North
America, Europe and APAC)
have been analyzed.
The market dynamics such as growth drivers, market trends and
challenges are analyzed in-depth.
The competitive landscape of the market, along with the company
profiles of leading players (Gilead Sciences, GSK, Roche Holding,
Boehringer Ingelheim, Cipla and Abbvie) are also presented in
detail.
Key Target Audience:
Antiretroviral Therapy Providers
Hospitals/Clinics
Healthcare Companies
End Users (Businesses/Consumers)
Investment Banks
Government Bodies & Regulating Authorities
Read the full report:
https://www.reportlinker.com/p05897001/?utm_source=PRN
About Reportlinker
ReportLinker is an award-winning market research solution.
Reportlinker finds and organizes the latest industry data so you
get all the market research you need - instantly, in one place.
__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001
View original
content:http://www.prnewswire.com/news-releases/global-antiretroviral-therapy-market-nrti-nnrti-protease-inhibitors--integrase-inhibitors-insights--forecast-with-potential-impact-of-covid-19-2020-2024-301064560.html
SOURCE Reportlinker